Cargando…

Health-related quality of life in epilepsy patients receiving anti-epileptic drugs at National Referral Hospitals in Uganda: a cross-sectional study

BACKGROUND: Epilepsy is a devastating disorder that impacts on patients’ quality of life, irrespective of use of anti epileptic drugs (AEDs). This study estimates the health-related quality of life (HRQOL) and its associated predictors among epilepsy patients receiving AEDs. METHODS: A total of 175...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabukenya, Anne M, Matovu, Joseph KB, Wabwire-Mangen, Fred, Wanyenze, Rhoda K, Makumbi, Fredrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999846/
https://www.ncbi.nlm.nih.gov/pubmed/24725904
http://dx.doi.org/10.1186/1477-7525-12-49
_version_ 1782313547025350656
author Nabukenya, Anne M
Matovu, Joseph KB
Wabwire-Mangen, Fred
Wanyenze, Rhoda K
Makumbi, Fredrick
author_facet Nabukenya, Anne M
Matovu, Joseph KB
Wabwire-Mangen, Fred
Wanyenze, Rhoda K
Makumbi, Fredrick
author_sort Nabukenya, Anne M
collection PubMed
description BACKGROUND: Epilepsy is a devastating disorder that impacts on patients’ quality of life, irrespective of use of anti epileptic drugs (AEDs). This study estimates the health-related quality of life (HRQOL) and its associated predictors among epilepsy patients receiving AEDs. METHODS: A total of 175 epilepsy patients already receiving AED for at least 3 months were randomly selected and interviewed from mental clinics at Mulago and Butabika national referral hospitals in Uganda between May - July 2011. A HRQOL index, the primary outcome, was constructed using items from Quality Of Life in Epilepsy Inventory (QOLIE-31) and the Hospital Anxiety and Depression Scale (HADS) questionnaires. The internal consistency and adequacy of these items was also computed using Cronbach's alpha and Kaiser-Meyer-Olkin tests. Partial correlations were used to evaluate the contribution of the health dimensions (mental, psychological, social, physical functioning and emotional well being) and, multiple linear regressions to determine factors independently associated with HRQOL. RESULTS: Just about half of the respondents (54%) were males, and nearly two thirds (62%) had received AEDs for at least 12 months. The average age was 26.6 years (SD = 11.1). The overall HRQOL mean score was 58 (SD = 13) on a scale of 0–100. The average scores of different dimensions or subscales ranged from 41 (physical) to 65 (psychological). At least three quarters (75%) of all subscales had good internal consistency and adequacy. The largest variations in the overall HRQOL were explained by social and mental functioning; each accounting for about 30% of the difference in the HRQOL but seizure control features explained a little (6%) variation. Factors negatively associated with HRQOL were poly-therapy (-1.16, p = 0.01) and frequency of seizures (-2.29, p = 0.00). Other factors associated with overall HRQOL included drug side effects, sex, marital status and education. Duration on AEDs was not a significant predictor of HRQOL. CONCLUSION: The HRQOL for epilepsy patients on AEDs is very low. The predictors of low HRQOL were socio factors (marital status, education) and drug side effects, frequency of seizure, and type of therapy.
format Online
Article
Text
id pubmed-3999846
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39998462014-04-26 Health-related quality of life in epilepsy patients receiving anti-epileptic drugs at National Referral Hospitals in Uganda: a cross-sectional study Nabukenya, Anne M Matovu, Joseph KB Wabwire-Mangen, Fred Wanyenze, Rhoda K Makumbi, Fredrick Health Qual Life Outcomes Research BACKGROUND: Epilepsy is a devastating disorder that impacts on patients’ quality of life, irrespective of use of anti epileptic drugs (AEDs). This study estimates the health-related quality of life (HRQOL) and its associated predictors among epilepsy patients receiving AEDs. METHODS: A total of 175 epilepsy patients already receiving AED for at least 3 months were randomly selected and interviewed from mental clinics at Mulago and Butabika national referral hospitals in Uganda between May - July 2011. A HRQOL index, the primary outcome, was constructed using items from Quality Of Life in Epilepsy Inventory (QOLIE-31) and the Hospital Anxiety and Depression Scale (HADS) questionnaires. The internal consistency and adequacy of these items was also computed using Cronbach's alpha and Kaiser-Meyer-Olkin tests. Partial correlations were used to evaluate the contribution of the health dimensions (mental, psychological, social, physical functioning and emotional well being) and, multiple linear regressions to determine factors independently associated with HRQOL. RESULTS: Just about half of the respondents (54%) were males, and nearly two thirds (62%) had received AEDs for at least 12 months. The average age was 26.6 years (SD = 11.1). The overall HRQOL mean score was 58 (SD = 13) on a scale of 0–100. The average scores of different dimensions or subscales ranged from 41 (physical) to 65 (psychological). At least three quarters (75%) of all subscales had good internal consistency and adequacy. The largest variations in the overall HRQOL were explained by social and mental functioning; each accounting for about 30% of the difference in the HRQOL but seizure control features explained a little (6%) variation. Factors negatively associated with HRQOL were poly-therapy (-1.16, p = 0.01) and frequency of seizures (-2.29, p = 0.00). Other factors associated with overall HRQOL included drug side effects, sex, marital status and education. Duration on AEDs was not a significant predictor of HRQOL. CONCLUSION: The HRQOL for epilepsy patients on AEDs is very low. The predictors of low HRQOL were socio factors (marital status, education) and drug side effects, frequency of seizure, and type of therapy. BioMed Central 2014-04-12 /pmc/articles/PMC3999846/ /pubmed/24725904 http://dx.doi.org/10.1186/1477-7525-12-49 Text en Copyright © 2014 Nabukenya et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Nabukenya, Anne M
Matovu, Joseph KB
Wabwire-Mangen, Fred
Wanyenze, Rhoda K
Makumbi, Fredrick
Health-related quality of life in epilepsy patients receiving anti-epileptic drugs at National Referral Hospitals in Uganda: a cross-sectional study
title Health-related quality of life in epilepsy patients receiving anti-epileptic drugs at National Referral Hospitals in Uganda: a cross-sectional study
title_full Health-related quality of life in epilepsy patients receiving anti-epileptic drugs at National Referral Hospitals in Uganda: a cross-sectional study
title_fullStr Health-related quality of life in epilepsy patients receiving anti-epileptic drugs at National Referral Hospitals in Uganda: a cross-sectional study
title_full_unstemmed Health-related quality of life in epilepsy patients receiving anti-epileptic drugs at National Referral Hospitals in Uganda: a cross-sectional study
title_short Health-related quality of life in epilepsy patients receiving anti-epileptic drugs at National Referral Hospitals in Uganda: a cross-sectional study
title_sort health-related quality of life in epilepsy patients receiving anti-epileptic drugs at national referral hospitals in uganda: a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999846/
https://www.ncbi.nlm.nih.gov/pubmed/24725904
http://dx.doi.org/10.1186/1477-7525-12-49
work_keys_str_mv AT nabukenyaannem healthrelatedqualityoflifeinepilepsypatientsreceivingantiepilepticdrugsatnationalreferralhospitalsinugandaacrosssectionalstudy
AT matovujosephkb healthrelatedqualityoflifeinepilepsypatientsreceivingantiepilepticdrugsatnationalreferralhospitalsinugandaacrosssectionalstudy
AT wabwiremangenfred healthrelatedqualityoflifeinepilepsypatientsreceivingantiepilepticdrugsatnationalreferralhospitalsinugandaacrosssectionalstudy
AT wanyenzerhodak healthrelatedqualityoflifeinepilepsypatientsreceivingantiepilepticdrugsatnationalreferralhospitalsinugandaacrosssectionalstudy
AT makumbifredrick healthrelatedqualityoflifeinepilepsypatientsreceivingantiepilepticdrugsatnationalreferralhospitalsinugandaacrosssectionalstudy